Startseite/Aktien/ARTV

ARTV

USD

Artiva Biotherapeutics Inc. Common Stock

$1.800-0.200 (-10.000%)

Echtzeitkurs

Healthcare

Biotechnologie

Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen

Unternehmensfundamentaldaten

Handelsstatistiken

Marktkennzahlen

Eröffnung

$2.000

Hoch

$2.000

Tief

$1.800

Volumen

0.18M

Unternehmensfundamentaldaten

Marktkapitalisierung

49.2M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.33M

Börse

NGM

Währung

USD

52-Wochen-Spanne

Tief $1.78Aktuell $1.800Hoch $17.31

Ähnliche Nachrichten

11. Juni 2025 · 11:03

Analyst Upgrades

HC Wainwright & Co. Assumes Artiva Biotherapeutics at Buy, Announces Price Target of $12

HC Wainwright & Co. analyst Emily Bodnar assumes Artiva Biotherapeutics with a Buy rating and announces Price Target of $12.

HC Wainwright & Co. Assumes Artiva Biotherapeutics at Buy, Announces Price Target of $12

28. Mai 2025 · 20:05

GlobeNewswire

Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference

SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (NASDAQ:ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients

Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference

Ähnliche Aktien

WTFCP

Wintrust Financial Corporation Depositary Shares Each Representing a 1/1000th Interest in a Share of 6.875% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series E

NASDAQ

Großbanken